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The Environmental Genome
Project: Suggestions and
Concerns
The NIEHS held a Symposium on the
Environmental Genome Project on 17-18
October 1997 at the National Institutes of
Health in Bethesda, Maryland. The pur-
pose ofthe meeting was to facilitate a free
exchange of information about the
Environmental Genome Project among "a
diverse group of scientists working in the
areas of genetics, gene-environment inter-
actions, molecular epidemiology, and
issues ofgenetic testing" (1). After attend-
ing this meeting and reading the recent
reports on the Environmental Genome
Project in Science (2) and Nature (3), we
are concerned that several important issues
ofinterest to the readers ofEnvironmental
Health Perspectives are not being adequate-
lyaddressed bythe NIEHS.
The goal of the Environmental
Genome Project is to "facilitate identifica-
tion of functionally important polymor-
phisms in environment response genes that
may determine differences in disease risks
to environmental exposures" (1). To this
end, the NIEHS proposes to establish a
repository of1,000 anonymous DNA sam-
ples representing the population of the
United States in order to catalog allelic
variants in 200 genes and foster epidemio-
logic studies ofgene-environment interac-
tions in the etiology ofhuman diseases. At
the symposium and in the Science article
(2), thepotential importance ofgene-envi-
ronment interactions in various diseases
was recognized and the potential benefits
of a central repository ofdata on a set of
critical risk-mediating genes were clearly
enunciated. Two issues, however, have not
been adequately addressed: sample size and
public policyimplications.
We have serious doubts that the
Environmental Genome Project's proposed
sample size of 1,000 individuals is large
enough to provide stable estimates ofallele
frequencies in subgroups ofthe population.
Many ofthe most promising candidate sus-
ceptibility genes have allelic variations that
affect less than 5% ofthepopulation, and the
prevalence ofmany ofthese polymorphisms
differs markedly among ethnic groups. If1%
ofthe people in the U.S. population carry a
polymorphism for a certain gene, for exam-
ple, we would expect 10 individuals out of
the 1,000 individuals in the study to carry
thatpolymorphism. Ifthose 10 arethen to be
subdivided into gender/racial/ethnic/sub-
groups, thesamplesizeisdearlyinadequateto
provide precise estimates ofthe prevalence of
the polymorphism in the subgroups. Yet pre-
cise estimates ofthepopulation prevalence are
exactly the kind ofinformation needed by
epidemiologists planningstudies oftheroleof
such genes in disease etiologies. That infor-
mationisoftendifficult tofindornonexistent
in the current literature, much ofwhich is
characterized by small, nonpopulation-based
studies thataredifficult to generalize. It is dif-
ficult to conceive why the Environmental
Genome Project would spend so much time
and money only to find that 1,000 subjects
were not nearly enough. Given the potential
importance of this population-based data,
and cognizant ofthe budgetary constraints, it
would seem wiser to ensure the value ofthe
data by increasing the sample size and
decreasing the number ofgenes targeted for
sequencing.
Concerning the sampling procedure,
the NIEHS appears to have planned to
collect samples from individuals rather
than using existing archived samples. This
will involve a considerable expense. An
alternative, cost-saving strategy, which
does not appear to have been seriously
explored, would be to use the archived
lymphocyte cell lines from the National
Health and Nutrition Examination Survey
(NHANES) III study as the source of
DNA for the Environmental Genome
Project. The NHANES III study popula-
tion is large (over 8,000) and is popula-
tion-based, a representative sample of the
entire U.S. population. A further advan-
tage ofusing this database is that genotype
data can be linked to an enormous data-
base of health and nutrition variables.
Strategies for preserving anonymity are
currently being investigated by the Centers
for Disease Control and Prevention.
We are also concerned about the societal
ramifications ofthe Environmental Genome
Project. 'While the recent symposium did
address certain ethical and policy issues such
as insurance discrimination, other issues
unique to the Environmental Genome
Project received little attention. One of the
project's goals is to improve risk assessment
and regulation by government agencies
through specific information about vulnera-
ble populations. How this information is to
be used in risk-based regulation in a hetero-
geneous society is as yet unclear. Should
employers be able to transfer chemicallysen-
sitive workers to jobs with lower exposure
levels rather than reducing exposure levels to
a safe level for all? Could employers expose
more resistant workers to higher exposure
levels? In cases ofalleged chemical injury,
would lawyers misuse knowledge ofgenetic
susceptibilities? The Environmental
Genome Project, ofcourse, cannot be held
accountable for such misuses, but since the
project aims to follow the lead of the
Human Genome Project in channeling
some of its resources into exploring ethical
concerns, it seems logical to focus on ethical
issues specific to the Environmental
Genome Project before work progresses fur-
ther. This may require educating courts and
regulators about what can and cannot be
known about risk-mediating genes in given
individuals andpopulations.
Basic scientists have rarely had to
address broad public policy issues resulting
from their investigations, but genetics has
increasingly become, like epidemiology, as
much a tool forpublic health as a scientific
discipline. The point on which everyone
seems to agree is that improving public
health is the primary goal of biomedical
research. It will take careful thinking to
ensure that the Environmental Genome
Project serves this purpose.
Christopher A. Loffredo
Ellen K. Silbergeld
Program in Human Health and
the Environment
University ofMaryland School
ofMedicine
Baltimore, Maryland
MarkParascandola
NIH Historical Office
National Institutes ofHealth
Bethesda, Maryland
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Response: Environmental
Genome Project
The letter from Loffredo, Silbergeld, and
Parascandola raises several interesting issues
that I would like to address in the context
ofthe overall concept ofthe Environmental
Genome Project. The Environmental
Genome Project is an outgrowth ofa long-
standing interest on the part ofthe NIEHS
and the larger scientific community in the
relationship between environmental expo-
sure and disease and the influence ofgenet-
ics upon this relationship. In their letter,
Loffredo, Silbergeld, and Parascandola
express concern about whether the sample
size proposed for initial studies by the
Environmental Genome Project is suffi-
cient for assignment of allele frequencies,
and they urge caution in dealing with the
ethical, social, and legal implications ofthe
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proposed research. These are important
issues that should be addressed by the
Environmental Genome Project. Issues
such as these should be carefully considered
and addressed during the early stage ofthe
project. As noted at the beginning of the
Environmental Genome Project sympo-
sium, the project is evolving and is a work
in progress. As with any evolving program,
it will continue to be molded by new ideas,
information, and technologies.
The goal of the initial phase of the
Environmental Genome Project is to stimu-
late research in the area of polymorphism
discovery. This phase of the project does
not specifically seek to assign polymor-
phism frequency. An allele has to be present
only once in the repository to be discov-
ered, yet accurately estimating the frequen-
cy of an allele in different ethnic groups
requires genotyping of large numbers of
individuals. Once polymorphisms (or alle-
les) have been discovered, study groups can
be held to consider the research required for
assignment of allele frequency. While the
Environmental Genome Project does not
seek to assign allele frequencies, we are
aware of the importance of accurate allele
frequency estimates for future epidemiolog-
ic studies and the large sample sizes such
estimates will require. It is important to
considerwhether the sample size selected by
the Environmental Genome Project will
provide sufficient power to discover most
alleles relevant to gene-environment inter-
actions. Clearly, sampling 500 to 1,000
individuals will be adequate to identify
many new polymorphisms. As pointed out
during the symposium, sampling this num-
ber of individuals is adequate to identify
most ofthe polymorphisms occurring com-
monly in the U.S. population. All of the
newly identified polymorphisms will have
the potential to be involved in gene-envi-
ronment interactions, although none of
them will be guaranteed to be so involved.
It is also clear that various combinations of
alleles may uniquely collaborate in environ-
mentally associated disease. These allele
combinations will, ofcourse, be present in
the population at lower levels than each
allele alone. As was clearly pointed out at
the Environmental Genome Project sympo-
sium, studies of gene-environment or
gene-gene interactions will require very
large sample sizes. Planning for both the
technical means of rapid genotyping and
the large number ofsamples for future epi-
demiologic studies is a key component of
the Environmental Genome Project.
In their letter, Loffredo, Silbergeld, and
Parascandola mention the potential useful-
ness of the archived lymphocyte cell lines
from the NHANES III study and they
suggest that this collection has not been
explored as a resource for DNA samples. In
fact, NHANES III cell lines will be used by
the Environmental Genome Project. A
repository ofsamples is being identified by
the National Human Genome Research
Institute, National Institutes of Health, in
partnership with the Centers for Disease
Control and Prevention. More than one-
half of the repository of samples will be
from NHANES III.
As pointed out by Loffredo, Silbergeld,
and Parascandola, another challenge to the
Environmental Genome Project is in the
area ofits ethical, legal, and social implica-
tions. Symposium attendees discussed this
topic in detail. These issues are complex and
many-layered. It is highly unlikely that all
the layers and nuances of the issues have
been uncovered or that they will become
simpler as the project evolves. To do justice
to this component of the Environmental
Genome Project, it is essential that sensitivi-
tyto these issues is upheld and that an effort
is made to foster and maintain an open dia-
logue on these implications with both the
scientificand nonscientific community.
One ofthe responsibilities faced by the
Environmental Genome Project is to pro-
vide the science base upon which society
can make better informed risk manage-
ment decisions. We do not know nearly
enough at the present time about how
genetic susceptibility and environmental
exposure collaborate in disease. The main
goal ofthe Environmental Genome Project
is to enhance population-based research
toward identifying environmental expo-
sure/disease relationships. As population
susceptibilities are better understood, we
will be in a better position than we are in
today to make informed decisions about
risk management. The approach proposed
by the Environmental Genome Project
offers great scientific opportunity and the
potential to improve public health. To
maximize our potential to enhance our
health and our knowledge, we should
remain open to new understanding and
evolving technology or resources that
might inspire a change in our approach to
these important questions.
SamuelWilson
NIEHS
Research Triangle Park, North Carolina
Interregional Differences
Undermine Sperm Trend
Conclusions
The reanalysis ofglobal trends in reported
human sperm counts by Swan et al. (1)
concluded that a decline in sperm densities
was observed in the United States
(1938-1988) and in Europe (1971-1990)
but not in non-Western countries
(1978-1989). The report notes that recent
studies from Europe and the United States
indicate large interregional differences in
sperm density. Interregional differences
noted in the United States (NewYork City
vs. Los Angeles, CA) were as large as the
reported differences in mean sperm density
in 1938 versus 1990.
Regional heterogeneity should alert us
to be cautious in interpreting temporal
trends in reported sperm densities for each
region (2). The only completely certain
conclusion from the analysis ofSwan et al.
(1) is that there is a significant trend over
time for sperm density studies to be
reported from locations in the United
States and Europe with lower sperm densi-
ties, while such a trend was not observed
in reported studies from non-Western
countries.
This limited conclusion is consistent
with the data from single center studies
where interregional differences are not a
likely confounding factor. Single center
studies in Europe report that sperm densi-
ties have declined over the last 10-20
years in Belgium (3), Finland (necropsy
study) (4), London (area served by the
Thames River water authority) (5), Paris
(6), and Scotland (7) but not in Denmark
(8), Finland (sperm count study) (9),
London (outside area served by the
Thames River water authority) (5), and
Toulouse, France (10). Single center stud-
ies in the United States have reported no
decline in sperm counts over the last
10-20 plus years in Los Angeles (11),
New York City (11,12), Roseville,
Minnesota (11), Seattle, Washington (13),
and Wisconsin (14).
Given the inherent limitations in
analysis of retrospective studies, prospec-
tive studies of human sperm counts are
needed to determine trends in semen qual-
ity and to identify possible causes where
temporal trends are observed (15).
John Heinze
JohnAdamsAssociates
Washington, D.C.
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